background image

Triple Negative Breast Cancer Clinical Trials

Find clinical trials for triple negative breast cancer. Search for triple negative breast cancer clinical trials in different cities and states across the United States.

Filter
1
Active & ResponsiveNew

Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients

for
Triple Negative Breast Cancer
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06845319

Phase2, Recruiting
Active & ResponsiveNew

Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Nashville TN
Sponsor: Vandana Abramson

Sex: All

Age: 18+

Code: NCT07016399

Phase2, Recruiting
Active & Responsive

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

for
Leptomeningeal Disease, Triple Negative Breast Cancer,
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05809752

Phase1, Recruiting
Active & Responsive

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

for
Solid Tumor, Adult, Colorectal Cancer,
Location: Gilbert AZ, Phoenix AZ, La Jolla CA, Palo Alto CA,
Sponsor: A2 Biotherapeutics Inc.

Sex: All

Age: 18+

Code: NCT04981119

Recruiting
Active & Responsive

Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications

for
Triple Negative Breast Cancer (TNBC),
Location: Denver CO, Boston MA, Grand Rapids MI, New York NY,
Sponsor: Boundless Bio

Sex: All

Age: 18+

Code: NCT05827614

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy

for
Locally Advanced Breast Cancer, Triple Negative Breast Cancer,
Location: Beverly Hills CA, Palo Alto CA, Santa Monica CA,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT06449222

Phase2, Recruiting
Active & Responsive

Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies

for
Non-Small Cell Lung Cancer, Renal Cell Carcinoma,
Location: Duarte CA, Sacramento CA, San Diego CA, Atlanta GA,
Sponsor: Janux Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT05783622

Phase1, Recruiting
Active & Responsive

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

for
Pancreatic Ductal Adenocarcinoma, Non-small Cell Lung Cancer,
Location: Los Angeles CA, Palo Alto CA, Boston MA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06562192

Phase1, Recruiting
Active & Responsive

Study of Screening Brain MRIs in Stage IV Breast Cancer

for
Triple Negative Breast Cancer, HER2-positive Breast Cancer,
Location: Clearwater FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Sex: All

Age: 18+

Code: NCT05115474

Recruiting
Active & Responsive

Study of XB010 in Subjects With Solid Tumors

for
Locally Advanced or Metastatic Solid Tumors,
Location: Duarte CA, Washington D.C. DC, St Louis MO,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06545331

Phase1, Recruiting